Graham Capital Management L.P. Makes New $1.02 Million Investment in Henry Schein, Inc. (NASDAQ:HSIC)

Graham Capital Management L.P. acquired a new position in Henry Schein, Inc. (NASDAQ:HSICFree Report) during the fourth quarter, HoldingsChannel reports. The institutional investor acquired 14,663 shares of the company’s stock, valued at approximately $1,015,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of HSIC. Palestra Capital Management LLC bought a new position in Henry Schein during the fourth quarter valued at approximately $182,988,000. Lyrical Asset Management LP bought a new position in Henry Schein during the fourth quarter valued at approximately $126,655,000. Norges Bank bought a new position in Henry Schein during the fourth quarter valued at approximately $103,301,000. National Bank of Canada FI lifted its position in Henry Schein by 102.4% during the fourth quarter. National Bank of Canada FI now owns 1,084,511 shares of the company’s stock valued at $75,048,000 after purchasing an additional 548,561 shares during the period. Finally, Raymond James Financial Inc. bought a new position in Henry Schein during the fourth quarter valued at approximately $34,720,000. Hedge funds and other institutional investors own 96.62% of the company’s stock.

Insider Buying and Selling at Henry Schein

In other Henry Schein news, Director Philip A. Laskawy sold 2,604 shares of Henry Schein stock in a transaction on Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total value of $184,988.16. Following the sale, the director now directly owns 24,805 shares in the company, valued at approximately $1,762,147.20. The trade was a 9.50% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Bradford C. Connett sold 4,036 shares of Henry Schein stock in a transaction on Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total transaction of $287,161.40. Following the completion of the transaction, the chief executive officer now directly owns 62,688 shares of the company’s stock, valued at $4,460,251.20. The trade was a 6.05% decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.08% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on HSIC shares. Piper Sandler lowered their price objective on shares of Henry Schein from $83.00 to $77.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 30th. Barrington Research decreased their price target on shares of Henry Schein from $90.00 to $86.00 and set an “outperform” rating on the stock in a research report on Tuesday, May 6th. StockNews.com downgraded shares of Henry Schein from a “buy” rating to a “hold” rating in a research report on Thursday, April 17th. Jefferies Financial Group increased their price target on shares of Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a research report on Thursday, January 23rd. Finally, Wells Fargo & Company decreased their price target on shares of Henry Schein from $80.00 to $75.00 and set an “equal weight” rating on the stock in a research report on Tuesday, May 6th. Six investment analysts have rated the stock with a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, Henry Schein has a consensus rating of “Moderate Buy” and an average price target of $79.30.

Read Our Latest Report on HSIC

Henry Schein Stock Up 0.1%

Shares of HSIC stock opened at $70.54 on Wednesday. The company has a market capitalization of $8.59 billion, a price-to-earnings ratio of 29.03, a PEG ratio of 2.13 and a beta of 0.87. Henry Schein, Inc. has a one year low of $60.56 and a one year high of $82.49. The company’s fifty day moving average price is $67.52 and its 200-day moving average price is $71.45. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82.

Henry Schein (NASDAQ:HSICGet Free Report) last announced its quarterly earnings results on Monday, May 5th. The company reported $1.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.11 by $0.04. The company had revenue of $3.17 billion for the quarter, compared to the consensus estimate of $3.24 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. Henry Schein’s revenue for the quarter was down .1% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.10 EPS. Sell-side analysts expect that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Henry Schein Profile

(Free Report)

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Read More

Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSICFree Report).

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.